• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 LC-HRMS 测定 AAV5 载体的 Sulfo-tag 结合程度,并评估其对抗体结合亲和力和桥接测定灵敏度的影响。

Determining the Degree of Sulfo-tag Conjugation to AAV5 Vectors by LC-HRMS and Evaluating the Effects on Antibody Binding Affinity and Bridging Assay Sensitivity.

机构信息

Clinical Pharmacology, Pharmacometrics, & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA.

Translational Sciences and Diagnostics, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA.

出版信息

AAPS J. 2024 Sep 16;26(6):104. doi: 10.1208/s12248-024-00970-2.

DOI:10.1208/s12248-024-00970-2
PMID:39285067
Abstract

Pre-existing anti-AAV antibodies can be detected using ligand binding-based assay formats. One such format is the MSD-based bridging assay, which uses sulfo-tag-labeled AAV vectors as detection reagents. However, no method has been developed to accurately measure the degree of sulfo-tag labeling on AAV vectors. To fill this gap, we developed a liquid chromatography-high resolution mass spectrometry (LC-HRMS) method to assess the degree of labeling (DoL) of sulfo-tag on AAV5 vectors, enabling the measurement of the DoL on AAV5 at six increasing levels of sulfo-tag challenge ratio. In addition, a Biacore-based assay was used to evaluate the binding affinity between an anti-AAV5 monoclonal antibody and various sulfo-tag labeled AAV5 vectors. The results indicated that increased DoL of sulfo-tag labeling on AAV5 did not compromise the binding affinity.Our study further employed the MSD-bridging assay to detect the binding Signal/Noise (S/N) ratios of four anti-AAV5 monoclonal antibodies (mAbs) to various sulfo-tag-labeled AAV5 vectors. The findings revealed a strong correlation between the degree of sulfo-tag labeling and both the S/N ratios and the sensitivity of MSD bridging assays. This result underscores the importance of optimizing the labeling of detection reagents to enhance assay sensitivity for detecting anti-AAV5 antibodies.

摘要

预先存在的抗 AAV 抗体可以使用基于配体结合的测定方法检测。其中一种方法是基于 MSD 的桥接测定法,该方法使用带 sulfo 标签的 AAV 载体作为检测试剂。然而,尚未开发出一种方法来准确测量 AAV 载体上 sulfo 标签的标记程度。为了填补这一空白,我们开发了一种液相色谱-高分辨质谱 (LC-HRMS) 方法来评估 AAV5 载体上 sulfo 标签的标记程度 (DoL),能够在六种不同的 sulfo 标签挑战比下测量 AAV5 的 DoL。此外,还使用 Biacore 测定法评估了抗 AAV5 单克隆抗体与各种带 sulfo 标签的 AAV5 载体之间的结合亲和力。结果表明,增加 AAV5 上 sulfo 标签标记的 DoL 不会影响其结合亲和力。我们的研究进一步采用 MSD 桥接测定法检测四种抗 AAV5 单克隆抗体 (mAb) 与各种带 sulfo 标签的 AAV5 载体的结合信号/噪声 (S/N) 比值。研究结果表明,sulfo 标签标记的程度与 S/N 比值和 MSD 桥接测定法的灵敏度之间存在很强的相关性。这一结果强调了优化检测试剂标记以提高检测抗 AAV5 抗体的测定灵敏度的重要性。

相似文献

1
Determining the Degree of Sulfo-tag Conjugation to AAV5 Vectors by LC-HRMS and Evaluating the Effects on Antibody Binding Affinity and Bridging Assay Sensitivity.通过 LC-HRMS 测定 AAV5 载体的 Sulfo-tag 结合程度,并评估其对抗体结合亲和力和桥接测定灵敏度的影响。
AAPS J. 2024 Sep 16;26(6):104. doi: 10.1208/s12248-024-00970-2.
2
High-Resolution Structural Characterization of a New Adeno-associated Virus Serotype 5 Antibody Epitope toward Engineering Antibody-Resistant Recombinant Gene Delivery Vectors.新型腺相关病毒血清型 5 抗体表位的高分辨率结构特征,有助于工程化抗体抗性重组基因传递载体。
J Virol. 2018 Dec 10;93(1). doi: 10.1128/JVI.01394-18. Print 2019 Jan 1.
3
Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity.1型腺相关病毒(AAV1)和AAV5抗体复合物结构揭示了细小病毒抗原反应性的进化共性。
J Virol. 2015 Feb;89(3):1794-808. doi: 10.1128/JVI.02710-14. Epub 2014 Nov 19.
4
Efficient removal of antibodies to adeno-associated viruses by immunoadsorption.免疫吸附法有效去除腺相关病毒抗体。
J Clin Apher. 2023 Oct;38(5):590-601. doi: 10.1002/jca.22069. Epub 2023 Jul 7.
5
Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5 and AAV1.通过依次给予AAV5和AAV1在小鼠和非人灵长类动物中成功实现重复肝脏基因递送。
Mol Ther. 2017 Aug 2;25(8):1831-1842. doi: 10.1016/j.ymthe.2017.05.003. Epub 2017 Jun 5.
6
Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells.5型腺相关病毒对树突状细胞的固有嗜性有助于诱导针对人类免疫缺陷病毒的强大免疫反应。
J Virol. 2006 Dec;80(24):11899-910. doi: 10.1128/JVI.00890-06. Epub 2006 Sep 27.
7
Seroprevalence of binding and neutralizing antibodies against 18 adeno-associated virus types in patients with neuromuscular disorders.神经肌肉疾病患者中针对 18 种腺相关病毒型的结合抗体和中和抗体的血清流行率。
Front Immunol. 2024 Sep 27;15:1450858. doi: 10.3389/fimmu.2024.1450858. eCollection 2024.
8
Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.健康人群血清 IgG 及中和因子针对腺相关病毒(AAV)血清型 1、2、5、6、8 和 9 的流行率:对使用 AAV 载体的基因治疗的影响。
Hum Gene Ther. 2010 Jun;21(6):704-12. doi: 10.1089/hum.2009.182.
9
Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A.全球甲型血友病患者中预先存在的抗 AAV5 及其他 AAV 血清型免疫的血清流行率。
Hum Gene Ther. 2022 Apr;33(7-8):432-441. doi: 10.1089/hum.2021.287. Epub 2022 Mar 16.
10
Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors.中国健康人群和 HIV-1 感染者体内针对 AAV2、AAV5 和 AAV8 的中和抗体:对使用 AAV 载体进行基因治疗的影响。
Gene Ther. 2014 Aug;21(8):732-8. doi: 10.1038/gt.2014.47. Epub 2014 May 22.

引用本文的文献

1
Synaptotoxic effects of extracellular tau are mediated by its microtubule-binding region.细胞外tau蛋白的突触毒性作用由其微管结合区域介导。
Acta Neuropathol. 2025 Jun 2;149(1):56. doi: 10.1007/s00401-025-02897-0.

本文引用的文献

1
Characterizing Adeno-Associated Virus Capsids with Both Denaturing and Intact Analysis Methods.用变性分析和完整分析方法对腺相关病毒衣壳进行表征。
J Am Soc Mass Spectrom. 2023 Dec 6;34(12):2811-2821. doi: 10.1021/jasms.3c00321. Epub 2023 Nov 27.
2
Understanding and Tackling Immune Responses to Adeno-Associated Viral Vectors.理解和解决腺相关病毒载体的免疫反应。
Hum Gene Ther. 2023 Sep;34(17-18):836-852. doi: 10.1089/hum.2023.119.
3
Chemical modification of AAV9 capsid with N-ethyl maleimide alters vector tissue tropism.用 N-乙基马来酰亚胺对 AAV9 衣壳进行化学修饰改变了载体的组织嗜性。
Sci Rep. 2023 May 25;13(1):8436. doi: 10.1038/s41598-023-35547-0.
4
Comparison of Pre-existing Anti-AAV8 Total Antibody Screening and Confirmatory Assays with a Cell-Based Neutralizing Assay in Normal Human Serum.正常人类血清中预先存在的抗AAV8总抗体筛查和确证试验与基于细胞的中和试验的比较
AAPS J. 2023 Apr 3;25(3):35. doi: 10.1208/s12248-023-00805-6.
5
Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy.抗 AAV 结合和中和抗体:检测及对 rAAV 介导基因治疗的影响。
Mol Ther. 2023 Mar 1;31(3):616-630. doi: 10.1016/j.ymthe.2023.01.010. Epub 2023 Jan 11.
6
Mass spectrometry in gene therapy: Challenges and opportunities for AAV analysis.基因治疗中的质谱分析:腺相关病毒分析面临的挑战与机遇
Drug Discov Today. 2023 Jan;28(1):103442. doi: 10.1016/j.drudis.2022.103442. Epub 2022 Nov 14.
7
MSD-based assays facilitate a rapid and quantitative serostatus profiling for the presence of anti-AAV antibodies.基于微球芯片的检测方法有助于针对抗腺相关病毒抗体的存在进行快速且定量的血清学状态分析。
Mol Ther Methods Clin Dev. 2022 Apr 20;25:360-369. doi: 10.1016/j.omtm.2022.04.008. eCollection 2022 Jun 9.
8
Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations.在腺相关病毒(AAV)基因转移治疗前检测预先存在的抗体:原理、经验教训及未来考量
Mol Ther Methods Clin Dev. 2022 Feb 26;25:74-83. doi: 10.1016/j.omtm.2022.02.011. eCollection 2022 Jun 9.
9
Prevalence of Pre-Existing Neutralizing Antibodies Against Adeno-Associated Virus Serotypes 1, 2, 5, 6, 8, and 9 in Sera of Different Pig Strains.不同猪品种血清中针对腺相关病毒血清型 1、2、5、6、8 和 9 的预先存在中和抗体的流行率。
Hum Gene Ther. 2022 Apr;33(7-8):451-459. doi: 10.1089/hum.2021.213.
10
Simple method to determine the concentration and incorporation ratio of ruthenium-labeled antibodies.测定放射性标记抗体浓度和结合比的简单方法。
Bioanalysis. 2022 Jan;14(1):19-28. doi: 10.4155/bio-2021-0197. Epub 2021 Nov 23.